Skip to main content
2025 CRT Conference Main banner
Back

CRT 2025

Atherosclerosis and Lipids

Atherosclerosis and Lipids Summit

Pleotropic Effects of PCSK9 Inhibitors

Sunday, March 9, 2025
11:19 AM – 11:27 AM ET

    Speaker(s)

  • Paul A. Gurbel, MD, FSCAI

    Director
    Sinai Center for Thrombosis Research and Drug Development
    Baltimore, Maryland, United States

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
Paul A. Gurbel, MD, FSCAI: No financial relationships to disclose